Atlas Trials

Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients

Clinical trial NCT01149109 · COMPLETED

Trial details

NCT number
NCT01149109
Sponsor
University Hospital, Bonn
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Glioblastoma
Start date
2010-10-01
Primary completion
2017-04-06
Enrollment
141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.